Search
Alirocumab
Alirocumab is a biopharmaceutical that obtained FDA approval in July 2015 as a second line treatment for high cholesterol in adults whose LDL-cholesterol (LDL-C) is not controlled by the combination of diet and statin treatment. It is a human monoclonal antibody part of the family of the PCSK9 inhibitors which are a...
Alirocumab Action Pathway (New)
smpdb.ca/view/SMP0125308Drug actionTherefore by inhibiting PCSK9's actions, alirocumab allows for more LDL-C reuptake by the liver and facilitates a higher rate of clearance. … Alirocumab is a PCSK9 inhibitor used as an adjunct to manage heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of
Enzymes: AlirocumabEvolocumab
go.drugbank.com/drugs/DB09303ApprovedInvestigationalEvolocumab is the second PCSK9 inhibitor on the market, first being alirocumab.
Unstable Angina Pectoris
go.drugbank.com/conditions/DBCOND0032056Primary Hyperlipidemia
go.drugbank.com/conditions/DBCOND0023471Homozygous Familial Hypercholesterolaemia (HoFH)
go.drugbank.com/conditions/DBCOND0135612Heterozygous Familial Hypercholesterolemia (HeFH)
go.drugbank.com/conditions/DBCOND0063124Drugs: Acetylsalicylic acid · Alirocumab · Atorvastatin · Bempedoic acid · Colesevelam · Enlicitide +6 moreEnlicitide
go.drugbank.com/drugs/DB22580ApprovedInvestigational[L63795] Unlike the monoclonal antibody PCSK9 inhibitors ([evolocumab], [alirocumab]), enlicitide is administered orally as a once-daily tablet.
Myocardial Infarction
go.drugbank.com/conditions/DBCOND0027900Drugs: Acetylsalicylic acid · Alirocumab · Atenolol · Atorvastatin · Bempedoic acid · Colchicine +13 moreStroke
go.drugbank.com/conditions/DBCOND0020609Drugs: Acetylsalicylic acid · Alirocumab · Apixaban · Atorvastatin · Cerebrolysin · Choline alfoscerate +14 more